These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17580499)

  • 1. The use of HAART for biological tumour therapy.
    Monini P; Toschi E; Sgadari C; Bacigalupo I; Palladino C; Carlei D; Barillari G; Ensoli B
    J HIV Ther; 2006 Sep; 11(3):53-6. PubMed ID: 17580499
    [No Abstract]   [Full Text] [Related]  

  • 2. [The thalidomide story and its lessons].
    Dolev E
    Harefuah; 2001 Jul; 140(7):663-7. PubMed ID: 11481978
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV-associated lymphoma.
    Kaplan LD
    AIDS Clin Rev; 1997-1998; ():349-73. PubMed ID: 9305455
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of HAART therapy on co-infection of tuberculosis and HIV cases for 9 years in Taiwan.
    Tseng SH; Jiang DD; Hoi HS; Yang SL; Hwang KP
    Am J Trop Med Hyg; 2009 Apr; 80(4):675-7. PubMed ID: 19346398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
    Vogel M; Rockstroh JK
    Curr Opin HIV AIDS; 2009 May; 4(3):171-5. PubMed ID: 19532046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.
    Powles T; Robinson D; Stebbing J; Shamash J; Nelson M; Gazzard B; Mandelia S; Møller H; Bower M
    J Clin Oncol; 2009 Feb; 27(6):884-90. PubMed ID: 19114688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncology impact of highly active antiretroviral therapy.
    Schlichemeyer R; Chambers C; Gill MJ
    J Oncol Pharm Pract; 2007 Mar; 13(1):17-25. PubMed ID: 17621563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer: the effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation.
    Grulich AE
    Curr Opin HIV AIDS; 2009 May; 4(3):183-7. PubMed ID: 19532048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Antiretroviral Therapy Initiation in HIV-Associated Malignancy: Is There Enough Evidence to Inform Clinical Guidelines?
    Oseso LN; Chiao EY; Bender Ignacio RA
    J Natl Compr Canc Netw; 2018 Aug; 16(8):927-932. PubMed ID: 30099368
    [No Abstract]   [Full Text] [Related]  

  • 10. [HIV infection 2007].
    Potthoff A; Brockmeyer N;
    Med Klin (Munich); 2007 Jul; 102(7):531-9. PubMed ID: 17634871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART.
    Chiappini E; Galli L; Tovo PA; Gabiano C; Lisi C; Gattinara GC; Esposito S; Viganò A; Giaquinto C; Rosso R; Guarino A; de Martino M
    AIDS; 2007 Jul; 21(12):1607-15. PubMed ID: 17630556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HIV agents. The changing picture of HIV.
    TreatmentUpdate; 2009 Feb; 21(2):1-3. PubMed ID: 19391260
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
    Polesel J; Clifford GM; Rickenbach M; Dal Maso L; Battegay M; Bouchardy C; Furrer H; Hasse B; Levi F; Probst-Hensch NM; Schmid P; Franceschi S;
    AIDS; 2008 Jan; 22(2):301-6. PubMed ID: 18097233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in the frequencies of torque teno virus subpopulations during HAART treatment in HIV-1-coinfected patients.
    Devalle S; Rua F; Morgado MG; Niel C
    Arch Virol; 2009; 154(8):1285-91. PubMed ID: 19585076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.
    Choi AI; Rodriguez RA; Bacchetti P; Volberding PA; Havlir D; Bertenthal D; Bostrom A; O'Hare AM
    Clin Infect Dis; 2007 Dec; 45(12):1633-9. PubMed ID: 18190326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART.
    Björkman P; Flamholc L; Molnegren V; Marshall A; Güner N; Widell A
    AIDS; 2007 Jul; 21(12):1641-3. PubMed ID: 17630561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Full viral suppression newest trend seen in the "post-HAART" era. New immunotherapy treatment could help with trend.
    AIDS Alert; 2008 Mar; 23(3):25-7. PubMed ID: 18661635
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drugs for antiretroviral therapy. The costs of HAART].
    Jablonowski H
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():21. PubMed ID: 19024911
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of depression in predicting antiretroviral adherence in Ugandan parents and their children initiating HAART in the MTCT-plus family treatment model: commentary on Jayne Byakika-Tusiime et al. 2009.
    Nakimuli-Mpungu E; Musisi S
    AIDS Behav; 2009 Oct; 13(5):969-72. PubMed ID: 19662522
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-AIDS-defining cancers in people with HIV infection: a sleeping giant?
    Powles T; Oliver T; Bower M
    J HIV Ther; 2006 Sep; 11(3):57-60. PubMed ID: 17580500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.